claim
3,4-Methylenedioxymethamphetamine (MDMA) is in the final stages of clinical research and may be employed for the treatment of post-traumatic stress disorder (PTSD) with assisted psychotherapy, according to Emerson et al. (2014), Feduccia and Mithoefer (2018), and Sessa (2017).

Authors

Sources

Referenced by nodes (2)